Literature DB >> 18251160

Different expression of apoptotic proteins between HBV-infected and non-HBV-infected hepatocellular carcinoma.

Chi-Sen Chang1, Shen-Min Huang, Hui-Hsuan Lin, Cheng-Chung Wu, Chau-Jong Wang.   

Abstract

BACKGROUND/AIMS: Hepatocellular carcinoma (HCC), an endemic consequence of the hepatitis B virus infection, has been the leading cause of cancer death in Taiwan. The aim of this study is to investigate the expression of apoptotic proteins in the tissues of HCC, and analyze the relationship between the expression of apoptotic proteins and hepatitis B virus infection.
METHODOLOGY: Twenty patients with HCC who underwent liver resection were enrolled in this study. Using Western blotting, we quantified the expression of PI-3K, Cdc-42, caspase 3, NF-kappaB, Bcl-2, Bad-p, Bax and Mcl-1 in tumor lesions and para-cancerous liver tissues.
RESULTS: The expression of PI-3K, Cdc-42, caspase 3, NF-kappaB, Bcl-2, Bad-p and Bax were higher in cancer tissues with HBV infection than para-cancerous liver tissues and cancer tissues without HBV infection. The expressions of PI-3K were significantly higher in cancer tissues with the HBV infection when compared to para-cancerous liver tissues. Furthermore, PI-3K concentrations were significantly higher in stages III and IV HCC than in stages I and II HCC (1.48+/-0.25 vs. 1.07+/-0.25, p<0.01). On the contrary, the expressions of Mcl-1 in cancer tissues were lower than para-cancerous liver tissue in both HCC with HBV infection and without HBV infection.
CONCLUSIONS: Our data indicate that different expressions of PI-3K, Cdc-42, Bcl-2 and Bad-p were noticed between HBV-infected and non-HBV infected HCC. Therefore, different transcriptional pathways may be involved in the developing of HCC between HBV-infected and non-HBV infected patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18251160

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  12 in total

1.  CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.

Authors:  Leilei Chen; Tim Hon Man Chan; Yun-Fei Yuan; Liang Hu; Jun Huang; Stephanie Ma; Jian Wang; Sui-Sui Dong; Kwan Ho Tang; Dan Xie; Yan Li; Xin-Yuan Guan
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

Review 2.  Cdc42 in oncogenic transformation, invasion, and tumorigenesis.

Authors:  Kristy Stengel; Yi Zheng
Journal:  Cell Signal       Date:  2011-04-16       Impact factor: 4.315

3.  Suppression of human hepatoma (HepG2) cell growth by nuclear factor-kappaB/p65 specific siRNA.

Authors:  Wei Wu; Dengfu Yao; Yilang Wang; Liwei Qiu; Wenli Sai; Junling Yang; Ninghua Yao; Shanshan Li; Yinzhu Bian; Zhiwei Wang; Dengbing Yao
Journal:  Tumour Biol       Date:  2010-07-14

4.  Label-free Proteomic Analysis of Exosomes Derived from Inducible Hepatitis B Virus-Replicating HepAD38 Cell Line.

Authors:  Xiaofang Jia; Jieliang Chen; Dominik A Megger; Xiaonan Zhang; Maya Kozlowski; Lijun Zhang; Zhong Fang; Jin Li; Qiaofang Chu; Min Wu; Yaming Li; Barbara Sitek; Zhenghong Yuan
Journal:  Mol Cell Proteomics       Date:  2017-02-27       Impact factor: 5.911

5.  Hepatitis B virus upregulates cellular inhibitor of apoptosis protein 2 expression via the PI3K/AKT/NF-κB signaling pathway in liver cancer.

Authors:  Jianping Lian; Yuanhua Zou; Ling Huang; Hao Cheng; Kai Huang; Junquan Zeng; Longhua Chen
Journal:  Oncol Lett       Date:  2020-01-08       Impact factor: 2.967

6.  Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA.

Authors:  Yun Shi; Si-Ye Wang; Min Yao; Wen-Li Sai; Wei Wu; Jun-Ling Yang; Yin Cai; Wen-Jie Zheng; Deng-Fu Yao
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

7.  Differential gene expression analysis of in vitro duck hepatitis B virus infected primary duck hepatocyte cultures.

Authors:  Sajith Nair; Devaki S Arathy; Aneesh Issac; Easwaran Sreekumar
Journal:  Virol J       Date:  2011-07-23       Impact factor: 4.099

8.  Hepatitis B Virus X Protein Stimulates Proliferation, Wound Closure and Inhibits Apoptosis of HuH-7 Cells via CDC42.

Authors:  Yongru Xu; Yingzi Qi; Jing Luo; Jing Yang; Qi Xie; Chen Deng; Na Su; Wei Wei; Deshun Shi; Feng Xu; Xiangping Li; Ping Xu
Journal:  Int J Mol Sci       Date:  2017-03-08       Impact factor: 5.923

9.  miR-185 inhibits cell migration and invasion of hepatocellular carcinoma through CDC42.

Authors:  Qingjun Zhang; Yun Chen; Ke Liu
Journal:  Oncol Lett       Date:  2018-06-15       Impact factor: 2.967

Review 10.  Rho GTPases modulate malignant transformation of tumor cells.

Authors:  Jose L Orgaz; Cecilia Herraiz; Victoria Sanz-Moreno
Journal:  Small GTPases       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.